NEFL and Alzheimer disease: The inverse correlation of levels of raised activated microglia in early AD with reduced plasma levels of NfL could suggest that initially boosting microglia activation, possibly with immunotherapy targeting abnormal protein aggregations, in early disease could be protective, but this hypothesis needs to be tested in further studies.